All Stories

  1. The origin of NMDA receptor hypofunction in schizophrenia

    Article • Pharmacology & Therapeutics, January 2020, Elsevier

    Dr Kazu Nakazawa

  2. AMPA Receptor Activation–Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine

    Article • Biological Psychiatry, October 2018, Elsevier

    Dr Kazu Nakazawa

  3. Schizophrenia-Like Dopamine Release Abnormalities in a Mouse Model of NMDA Receptor Hypofunction

    Article • Schizophrenia Bulletin, January 2018, Oxford University Press (OUP)

    Dr Kazu Nakazawa

  4. Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus

    Article • Neuropsychopharmacology, December 2017, Springer Science + Business Media

    Dr Kazu Nakazawa

  5. Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia

    Article • Schizophrenia, February 2017, Springer Science + Business Media

    Dr Kazu Nakazawa

  6. Electrophysiological evidence for defective fast-spiking GABAergic neurones in a schizophrenia model

    Article • Acta Physiologica, December 2016, Wiley

    Dr Kazu Nakazawa

  7. Cortical GluN2B deletion attenuates punished suppression of food reward-seeking

    Article • Psychopharmacology, July 2015, Springer Science + Business Media

    Dr Kazu Nakazawa

  8. NMDA receptor subunits and associated signaling molecules mediating antidepressant-related effects of NMDA-GluN2B antagonism

    Article • Behavioural Brain Research, July 2015, Elsevier

    Dr Kazu Nakazawa

  9. Impaired discrimination learning in interneuronal NMDAR-GluN2B mutant mice

    Article • Neuroreport, May 2015, Wolters Kluwer Health

    Dr Kazu Nakazawa

  10. Brain state-dependent abnormal LFP activity in the auditory cortex of a schizophrenia mouse model

    Article • Frontiers in Neuroscience, July 2014, Frontiers

    Dr Kazu Nakazawa

  11. Identification of Transcription Factors for Lineage-Specific ESC Differentiation

    Article • Stem Cell Reports, December 2013, Elsevier

    Dr Kazu Nakazawa

  12. Dysregulation of the axonal trafficking of nuclear-encoded mitochondrial mRNA alters neuronal mitochondrial activity and mouse behavior

    Article • Developmental Neurobiology, November 2013, Wiley

    Dr Kazu Nakazawa

  13. GluN2B in corticostriatal circuits governs choice learning and choice shifting

    Article • Nature Neuroscience, July 2013, Springer Science + Business Media

    Dr Kazu Nakazawa

  14. Social Isolation Exacerbates Schizophrenia-Like Phenotypes via Oxidative Stress in Cortical Interneurons

    Article • Biological Psychiatry, May 2013, Elsevier

    Dr Kazu Nakazawa

  15. Contribution of NMDA Receptor Hypofunction in Prefrontal and Cortical Excitatory Neurons to Schizophrenia-Like Phenotypes

    Article • PLoS ONE, April 2013, PLOS

    Dr Kazu Nakazawa

  16. Convergence of genetic and environmental factors on parvalbumin-positive interneurons in schizophrenia

    Article • Frontiers in Behavioral Neuroscience, January 2013, Frontiers

    Dr Kazu Nakazawa

  17. Hilar mossy cell circuitry controlling dentate granule cell excitability

    Article • Frontiers in Neural Circuits, January 2013, Frontiers

    Dr Kazu Nakazawa

  18. Preferential inactivation of Scn1a in parvalbumin interneurons increases seizure susceptibility

    Article • Neurobiology of Disease, January 2013, Elsevier

    Dr Kazu Nakazawa

  19. Hilar Mossy Cell Degeneration Causes Transient Dentate Granule Cell Hyperexcitability and Impaired Pattern Separation

    Article • Neuron, December 2012, Elsevier

    Dr Kazu Nakazawa

  20. GABAergic interneuron origin of schizophrenia pathophysiology

    Article • Neuropharmacology, March 2012, Elsevier

    Dr Kazu Nakazawa

  21. Acute d-serine treatment produces antidepressant-like effects in rodents

    Article • The International Journal of Neuropsychopharmacology, September 2011, Oxford University Press (OUP)

    Dr Kazu Nakazawa

  22. Chronic stress-induced hippocampal dendritic retraction requires CA3 NMDA receptors

    Article • Neuroscience, February 2011, Elsevier

    Dr Kazu Nakazawa

  23. Genetically Engineered Mice for Schizophrenia Research

    Article • January 2011, Springer Science + Business Media

    Dr Kazu Nakazawa

  24. Loss of GluN2B-Containing NMDA Receptors in CA1 Hippocampus and Cortex Impairs Long-Term Depression, Reduces Dendritic Spine Density, and Disrupts Learning

    Article • Journal of Neuroscience, March 2010, Society for Neuroscience

    Dr Kazu Nakazawa

  25. eIF2  Phosphorylation-Dependent Translation in CA1 Pyramidal Cells Impairs Hippocampal Memory Consolidation without Affecting General Translation

    Article • Journal of Neuroscience, February 2010, Society for Neuroscience

    Dr Kazu Nakazawa

  26. Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes

    Article • Nature Neuroscience, November 2009, Springer Science + Business Media

    Dr Kazu Nakazawa

  27. Lack of kainic acid-induced gamma oscillations predicts subsequent CA1 excitotoxic cell death

    Article • European Journal of Neuroscience, September 2009, Wiley

    Dr Kazu Nakazawa

  28. Chemically Inducible Inactivation of Protein Synthesis in Genetically Targeted Neurons

    Article • Journal of Neuroscience, May 2009, Society for Neuroscience

    Dr Kazu Nakazawa

  29. Notch1 Signaling in Pyramidal Neurons Regulates Synaptic Connectivity and Experience-Dependent Modifications of Acuity in the Visual Cortex

    Article • Journal of Neuroscience, October 2008, Society for Neuroscience

    Dr Kazu Nakazawa

  30. CA3 NMDA receptors are crucial for rapid and automatic representation of context memory

    Article • European Journal of Neuroscience, September 2006, Wiley

    Dr Kazu Nakazawa

  31. Inducible and Cell-Type Restricted Manipulation in the Entorhinal Cortex

    Article • Neuron, April 2006, Elsevier

    Dr Kazu Nakazawa

  32. Hippocampal CA3 NMDA Receptors Are Crucial for Adaptive Timing of Trace Eyeblink Conditioned Response

    Article • Journal of Neuroscience, February 2006, Society for Neuroscience

    Dr Kazu Nakazawa

  33. Erratum

    Article • Neuron, August 2003, Elsevier

    Dr Kazu Nakazawa

  34. NMDA Receptor-Dependent Ocular Dominance Plasticity in Adult Visual Cortex

    Article • Neuron, June 2003, Elsevier

    Dr Kazu Nakazawa

  35. Genetic neuroscience of mammalian learning and memory

    Article • Philosophical Transactions of the Royal Society B Biological Sciences, April 2003, Royal Society Publishing

    Dr Kazu Nakazawa

  36. Hippocampal CA3 NMDA Receptors Are Crucial for Memory Acquisition of One-Time Experience

    Article • Neuron, April 2003, Elsevier

    Dr Kazu Nakazawa

  37. Essential function of α-calcium/calmodulin-dependent protein kinase II in neurotransmitter release at a glutamatergic central synapse

    Article • Proceedings of the National Academy of Sciences, March 2003, Proceedings of the National Academy of Sciences

    Dr Kazu Nakazawa

  38. Requirement for Hippocampal CA3 NMDA Receptors in Associative Memory Recall

    Article • Science, May 2002, American Association for the Advancement of Science

    Dr Kazu Nakazawa

  39. Antibody specific for phosphorylated AMPA-type glutamate receptors at GluR2 Ser-696

    Article • Neuroscience Research, December 1995, Elsevier

    Dr Kazu Nakazawa

  40. Transient and persistent phosphorylation of AMPA-type glutamate receptor subunits in cerebellar Purkinje cells

    Article • Neuron, September 1995, Elsevier

    Tsutomu Hashikawa, Dr Kazu Nakazawa

  41. Immunohistochemical localization of protein phosphatase isoforms in the rat cerebellum

    Article • Neuroscience Research, March 1995, Elsevier

    Tsutomu Hashikawa, Dr Kazu Nakazawa

  42. On crucial roles of hippocampal NMDA receptors in acquisition and recall of associative memory

    Article • Cambridge University Press

    Dr Kazu Nakazawa